Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
AUGUST 4, 2021 |
NEJM
Adaptive Platform Trials: The Clinical Trial of the Future? (C)
JULY 2021 |
Ariel D. Stern and Sarah Mehta, Harvard Business Review
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
FEBRUARY 25, 2021 |
NEJM
Adaptive Platform Trials: The Clinical Trial of the Future? (B)
SEPTEMBER 2019 |
Ariel D. Stern and Sarah Mehta, Harvard Business Review
AUGUST 28, 2019 |
NATURE REVIEWS DRUG DISCOVERY
Adaptive Platform Trials: The Clinical Trial of the Future?
September 26, 2017 |
Ariel D. Stern and Sarah Mehta, Harvard Business Review
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
September 20, 2017 |
Dr. Brian M. Alexander, Dr. Sujuan Ba, Dr. Webster Cavenee, Dr. Timothy F. Cloughesy, Dr. W.K. Alfred Yung – American Association for Cancer Research